Feb 25, 2026 04:09PM
Feb 25, 2026 04:05PM
Feb 11, 2026 04:05PM
Oct 28, 2025 04:59PM
Oct 28, 2025 04:05PM
Aug 6, 2025 04:05PM
May 6, 2025 04:21PM Arcus Biosciences (RCUS) Misses Q1 EPS by 12c
May 6, 2025 04:05PM
Apr 22, 2025 04:05PM
Feb 25, 2025 04:36PM
Feb 25, 2025 04:05PM
Nov 6, 2024 05:11PM
Nov 6, 2024 04:22PM
Nov 5, 2024 09:02AM Arcus Biosciences (RCUS) Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10
Nov 5, 2024 09:00AM
Oct 30, 2024 09:00AM
Oct 22, 2024 04:05PM
Aug 8, 2024 04:05PM
Jul 25, 2024 04:05PM
Jun 2, 2024 08:00AM
Jun 1, 2024 08:00AM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
May 8, 2024 04:38PM
May 8, 2024 04:02PM
Apr 23, 2024 04:05PM
Feb 21, 2024 04:28PM
Feb 21, 2024 04:05PM
Feb 7, 2024 05:00PM
Jan 29, 2024 05:01PM Gilead Sciences (GILD), Arcus (RCUS) Announce Amended Collaboration and $320M Equity Investment
Jan 29, 2024 05:00PM
Nov 7, 2023 04:33PM
Nov 7, 2023 04:01PM
Nov 6, 2023 05:04PM
Nov 6, 2023 05:00PM
Oct 17, 2023 04:00PM
Aug 7, 2023 08:08AM Arcus Biosciences (RCUS) Tops Q2 EPS by 6c
Aug 7, 2023 08:00AM
Jun 3, 2023 01:30PM
May 15, 2023 08:30AM
May 9, 2023 05:02PM
May 9, 2023 04:05PM
Feb 28, 2023 04:38PM
Feb 28, 2023 04:05PM Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update
Dec 19, 2022 05:01PM
Dec 19, 2022 05:00PM
Dec 19, 2022 05:00PM
Nov 28, 2022 08:31AM
Nov 28, 2022 08:30AM
Nov 28, 2022 08:30AM
Nov 2, 2022 04:02PM Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
Aug 3, 2022 04:03PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All